Streetbeat News

Earnings

CIEN

Ciena (CIEN) has released its Q4 earnings report for the quarter ending October 2024. The report provides insights into the company's performance, comparing key metrics against Wall Street estimates and year-ago values.

Portfolio Pulse from

December 12, 2024 | 3:45 pm

FHTX

Foghorn Therapeutics (FHTX) has experienced a significant decline of 30.17% over the past four weeks. However, the stock is now in oversold territory, and Wall Street analysts are revising earnings estimates higher, suggesting a potential trend reversal.

Portfolio Pulse from

December 12, 2024 | 3:45 pm

HEI

Heico (HEI) is set to release its Q4 earnings, and analysts are focusing on key metrics beyond just top and bottom-line estimates to assess the company's performance for the quarter ending October 2024.

Portfolio Pulse from

December 12, 2024 | 3:30 pm

ADBE

Adobe's Q4 fiscal 2024 results exceeded earnings estimates, driven by strong adoption of Digital Media and Digital Experience. However, shares fell due to a weak outlook.

Portfolio Pulse from

December 12, 2024 | 3:30 pm

KEQU

Kewaunee Scientific (KEQU) reported an increase in fiscal Q2 earnings year-over-year, driven by strong domestic demand and the strategic acquisition of Nu Aire, despite facing revenue challenges.

Portfolio Pulse from

December 12, 2024 | 3:15 pm

CSR

Centerspace, managing over 13,000 apartments, shows signs of moderating growth. Q3 2024 results were affected by a capital increase for redeeming Series C preferred shares. With only 4% variable rate debt, it sees limited benefits from Fed rate cuts.

Portfolio Pulse from

December 12, 2024 | 3:00 pm

DAVE

Dave & Buster's shares dropped 20% following weak Q3 results, CEO resignation, and lack of guidance. The stock faces critical support levels with poor momentum indicators, declining revenue, negative comparable sales, and worsening margins, indicating potential further declines.

Portfolio Pulse from

December 12, 2024 | 3:00 pm

GOOS

Canada Goose reported mixed earnings with a revenue decline but beat estimates. EPS rose due to lower finance costs. FY25 guidance was revised downward, with limited growth potential due to luxury market challenges and macroeconomic headwinds. The stock is rated as a Hold.

Portfolio Pulse from

December 12, 2024 | 2:45 pm

CIEN

Ciena (CIEN) reported Q4 earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.66 per share and down from $0.75 per share a year ago.

Portfolio Pulse from

December 12, 2024 | 2:30 pm

MBXBF

Microbix has scheduled the release of its Q4 Fiscal 2024 results and a subsequent webinar discussion for December 19, 2024. This announcement is relevant for investors tracking the company's performance.

Portfolio Pulse from

December 12, 2024 | 12:15 pm